McKesson Europe AG operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares McKesson Europe AG with three other
drug stores in Europe:
sales of 692.96 million Euro [US$783.89 million]
Udg Healthcare Plc
(1.10 billion Euro [US$1.25 billion]
of which 70%
was Ashfield), and
Zur Rose Group AG
based in Switzerland
(1.21 billion Swiss Francs [US$1.20 billion]
McKesson Europe AG reported sales of 21.09 billion Euro (US$23.86 billion)
March of 2018.
increase of 2.2%
versus 2017, when the company's sales were 20.64 billion Euro.
Despite this increase, sales are still
below the level achieved in 2016, when McKesson Europe AG
reported sales of 21.41 billion Euro.
The sales level in 2018 was fairly close to the level five years ago: in 2013, McKesson Europe AG had sales
of 21.41 billion Euro.
Sales of Pharmacy Solutions saw an increase
2.2% in 2018, from
16.81 billion Euro to 17.18 billion Euro.